A Look At Hyliion Holdings (HYLN) Valuation After U.S. Navy And DARPA KARNO Test Selection
Hyliion Holdings HYLN | 0.00 |
Hyliion Holdings (HYLN) has moved into the spotlight after the U.S. Navy’s Office of Naval Research, working with DARPA, chose the USX-1 Defiant unmanned vessel to test the company’s KARNO onboard power technology.
The recent client win with the U.S. Navy and DARPA, together with progress on KARNO’s multi fuel capabilities and the latest quarterly update, has coincided with a sharp shift in sentiment. Hyliion’s share price delivered a 1 month share price return of 211.98% and a year to date share price return of 229.12%, while the 1 year total shareholder return of 399.17% contrasts with a 5 year total shareholder return that is still down 43.01%.
If this kind of move has you looking beyond a single stock, it could be a good time to hunt for other charged up ideas in 35 power grid technology and infrastructure stocks
With Hyliion’s shares surging recently and the stock trading above the current analyst price target, yet still showing an implied discount to intrinsic value, investors now face a key question: is there still an opportunity here, or is the market already pricing in future growth?
Most Popular Narrative: 20% Overvalued
Hyliion’s most followed narrative points to a fair value of $5 per share, which now sits below the recent close at $5.99, so the story has shifted.
Rising demand for reliable on site power at AI driven data centers, combined with the industry shift toward 800 volt DC architectures that match KARNO’s native output, positions Hyliion to win high value deployments that can materially expand product revenue and improve operating leverage.
Want to see what is baked into that premium tag? Revenue acceleration, margin reset and a punchy earnings multiple all sit at the core of this narrative.
Result: Fair Value of $5 (OVERVALUED)
However, you still need to weigh the risk that Hyliion stays pre commercial for longer and that nonbinding KARNO orders fail to convert into firm revenue.
Another View: DCF Paints A Different Picture
While the popular narrative suggests Hyliion is about 20% overvalued at $5.99 versus a $5 fair value, the SWS DCF model points in a different direction, with an estimate of $9.33. This difference indicates that the market may be underpricing Hyliion’s future cash flows, so which perspective do you think is more compelling?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Hyliion Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Seen enough to sense the tension between upside and risk here? Act while sentiment is fresh by weighing both the rewards and the concerns highlighted in the 2 key rewards and 1 important warning sign.
Looking for more investment ideas?
If Hyliion has caught your attention, do not stop here. The next winning idea in your portfolio could be hiding in plain sight on a screener.
- Target potential mispricing by scanning for quality companies trading below estimated value with the 49 high quality undervalued stocks.
- Strengthen your income stream by focusing on stocks with generous yields through the 10 dividend fortresses.
- Prioritize resilience by filtering for companies with robust finances using the solid balance sheet and fundamentals stocks screener (46 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
